Unicycive Therapeutics Announces Initial Positive Patient Satisfaction Findings from Pivotal Clinical Trial of Oxylanthanum Carbonate (OLC)

Source :: GlobeNewswire. July 10, 2024
Publication Year :: 2024
Abstract: - Patients preferred OLC more than 4 to 1 over their prior phosphate binder therapy - - Median daily pill burden reduced by half after switch to OLC - LOS [...]

Subjects :: Sevelamer carbonate -- Surveys
Medical research -- Surveys
Medicine, Experimental -- Surveys
Chronic kidney failure -- Surveys
Patient compliance -- Surveys
Patient satisfaction -- Surveys
Clinical trials -- Surveys
Phosphates -- Product development
Calcium carbonate -- Product development
Banking, finance and accounting industries
Business

Tools